Myomo (MYO) Net Margin Growth (1y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,580.00 |
| Jun 30, 2025 | -3,308.00 |
| Mar 31, 2025 | 6,692.00 |
| Dec 31, 2024 | -7,715.00 |
| Sep 30, 2024 | 2,945.00 |
| Jun 30, 2024 | 211.00 |
| Mar 31, 2024 | -2,544.00 |
| Dec 31, 2023 | 18,964.00 |
| Sep 30, 2023 | 3,136.00 |
| Jun 30, 2023 | 6,208.00 |
| Mar 31, 2023 | -394.00 |
| Dec 31, 2022 | 2,557.00 |
| Sep 30, 2022 | -2,439.00 |
| Jun 30, 2022 | 534.00 |
| Mar 31, 2022 | 5,394.00 |
| Dec 31, 2021 | -3,885.00 |
| Sep 30, 2021 | 9,719.00 |
| Jun 30, 2021 | 29,839.00 |
| Mar 31, 2021 | 31,693.00 |
| Dec 31, 2020 | 13,678.00 |
| Sep 30, 2020 | 31,550.00 |
| Jun 30, 2020 | -9,143.00 |
| Mar 31, 2020 | -3,456.00 |
| Dec 31, 2019 | 12,102.00 |
| Sep 30, 2019 | -2,449.00 |
| Jun 30, 2019 | 12,443.00 |
| Mar 31, 2019 | 33,981.00 |
| Dec 31, 2018 | 214,494.00 |
| Sep 30, 2018 | -17,743.00 |
| Jun 30, 2018 | 211,271.00 |
| Mar 31, 2018 | 868,601.00 |
| Dec 31, 2017 | -213,423.00 |
| Sep 30, 2017 | 39,972.00 |
| Jun 30, 2017 | -215,433.00 |